Hims & Hers Health is trading at €25.82, down -3.08%, as hotter-than-expected September inflation pressured U.S. stocks and raised concerns about higher interest rates.
- Reuters reported annual headline CPI of 3.7%, above the 3.6% forecast, and core CPI of 2.6%, above the 2.5% forecast.
- No clear company-specific event was verified as the direct cause of the October 14 move. Securities-litigation reminders circulating describe the earlier July 29 decline, not today’s trading.